Zai Lab Limited Share Price Mexican S.E.
Stocks
ZLAB N
US98887Q1040
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 810.00 MXN | +43.36% |
|
-.--% | - |
| 30/06 | Zai Lab Insider Sold Shares Worth $428,545, According to a Recent SEC Filing | MT |
| 16/06 | Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug | MT |
| Market Cap | 220.44Cr 3.86TCr 193.35Cr 179.08Cr 164.77Cr 311.66Cr 21TCr 317.72Cr 2.13TCr 837.1Cr 10TCr 827.78Cr 809.68Cr 36TCr | P/E 2026 * |
-8.86x | P/E 2027 * | -10.5x |
|---|---|---|---|---|---|
| Enterprise Value | 176.13Cr 3.08TCr 154.48Cr 143.08Cr 131.65Cr 249.01Cr 17TCr 253.85Cr 1.71TCr 668.83Cr 8.28TCr 661.38Cr 646.92Cr 29TCr | EV / Sales 2026 * |
3.93x | EV / Sales 2027 * | 3.05x |
| Free-Float |
95.17% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Zai Lab Limited
| 1 day | +43.36% |
| 3 years | 270.64 |  | 810 |
| 5 years | 270.64 | | 2,446.85 |
| 10 years | 270.64 | | 3,693.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ying Du
CEO | Chief Executive Officer | 61 | 01/04/2014 |
Ya jing Chen
DFI | Director of Finance/CFO | 58 | 07/07/2023 |
Rafael Amado
PSD | President | 62 | 01/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ying Du
CHM | Chairman | 61 | 01/04/2014 |
John Diekman
BRD | Director/Board Member | 83 | 01/01/2017 |
Peter Wirth
BRD | Director/Board Member | 75 | 01/01/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +43.36% | -.--% | - | - | 230.22Cr | |
| -0.22% | +2.04% | +16.79% | -8.03% | 6.76TCr | |
| -0.63% | -7.39% | +37.82% | +199.82% | 5.16TCr | |
| +0.36% | +40.00% | +40.00% | +40.00% | 4.3TCr | |
| +0.97% | -1.17% | -49.29% | -53.05% | 4.09TCr | |
| +4.96% | +0.27% | +55.75% | -24.80% | 2.94TCr | |
| -1.85% | -18.08% | +99.20% | -47.07% | 2.71TCr | |
| -2.12% | -1.20% | +66.54% | +84.42% | 2.33TCr | |
| +1.18% | +3.44% | +10.00% | +177.97% | 1.99TCr | |
| -2.12% | -3.92% | +61.37% | +130.60% | 1.69TCr | |
| Average | +4.39% | -2.60% | +37.58% | +55.54% | 3.55TCr | |
| Weighted average by Cap. | +0.44% | -2.32% | +30.97% | +47.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 45Cr 785.13Cr 39Cr 36Cr 34Cr 63Cr 4.29TCr 65Cr 434.43Cr 170.39Cr 2.11TCr 168.49Cr 164.81Cr 7.28TCr | 60Cr 1.04TCr 52Cr 48Cr 45Cr 84Cr 5.7TCr 86Cr 576.65Cr 226.16Cr 2.8TCr 223.64Cr 218.75Cr 9.67TCr |
| Net income | -24Cr -421.53Cr -21Cr -20Cr -18Cr -34Cr -2.31TCr -35Cr -233.24Cr -91Cr -1.13TCr -90Cr -88Cr -3.91TCr | -16Cr -273.79Cr -14Cr -13Cr -12Cr -22Cr -1.5TCr -23Cr -151.5Cr -59Cr -735.44Cr -59Cr -57Cr -2.54TCr |
| Net Debt | -44Cr -775.39Cr -39Cr -36Cr -33Cr -63Cr -4.24TCr -64Cr -429.04Cr -168.27Cr -2.08TCr -166.4Cr -162.76Cr -7.19TCr | -39Cr -677.51Cr -34Cr -31Cr -29Cr -55Cr -3.71TCr -56Cr -374.88Cr -147.03Cr -1.82TCr -145.39Cr -142.22Cr -6.28TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ZLAB Stock
- ZLAB N Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
